Clinical trial
WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS)
NCT02741817 is registered in ClinicalTrials.gov with Sheffield Teaching Hospitals NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS)
- Lead sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 26, 2016
- Completion date
- April 7, 2017
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.